AlloStim® In-Situ Vaccine in Pre-Treated Metastatic Colorectal Cancer
Clinical trial NCT01741038 · WITHDRAWN
Trial details
- NCT number
- NCT01741038
- Sponsor
- Mirror Biologics, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-01
- Primary completion
- 2019-12-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.